RGT 0.00% 28.5¢ argent biopharma limited

Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19, page-18

  1. 2,644 Posts.
    lightbulb Created with Sketch. 773
    no but most clinical trials don’t meet starting aims. To be saying boom based on a trial is ambitious.
    no a company needs to keep its focus on its primary business. This side game will cost money. Where is it coming from? That money and Human Resources takes away from primary objectives like Malta.
    dont have a crystal ball just playing the odds. When all the worlds scientists are focussing on this problem why would mxc be likely to succeed when others fail.
    added to that mxc track record of delivering on anything is not great
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.000(0.00%)
Mkt cap ! $13.79M
Open High Low Value Volume
28.5¢ 28.5¢ 28.0¢ $15.14K 53.18K

Buyers (Bids)

No. Vol. Price($)
2 73 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 3187 1
View Market Depth
Last trade - 13.52pm 29/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.